ADHD drug trial for teens halted early – what we know

NCT ID NCT06215144

Terminated Symptom relief Sponsor: Neurocentria, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new medicine called NRCT-101SR for teenagers aged 13 to 17 with ADHD. The goal was to see if it safely reduces ADHD symptoms compared to a placebo. The trial was stopped early, so results are limited. It involved 95 participants and used standard ADHD rating scales to measure changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

Contacts and locations

Locations

Accel Research Sites - Lakeland Clinical Research Unit

Lakeland, Florida, 33803, United States
Accel Research Sites Network - Maitland

Maitland, Florida, 32751, United States
Advanced Research Center, Inc

Anaheim, California, 92805, United States
Bio-Medical Research LLC

Miami, Florida, 33144, United States
Boston Clinical Trials Llc

Boston, Massachusetts, 02131, United States
CenExel ACMR Atlanta Center for Medical Research

Atlanta, Georgia, 30331, United States
CenExel iRS - iResearch Savannah

Savannah, Georgia, 31405, United States
Coastal Carolina Research Center - North Charleston

North Charleston, South Carolina, 29405, United States
DelRicht Research

New Orleans, Louisiana, 70155, United States
DelRicht Research

Prairieville, Louisiana, 70769, United States
Epic Medical Research - DeSoto

DeSoto, Texas, 75115, United States
Vector Clinical Trials

Las Vegas, Nevada, 89128, United States
iResearch Atlanta

Decatur, Georgia, 30030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.